ROCCO CARUSO M.D. NPI 1285630731

NPI Details

Rocco Caruso, M.D. is a hematology and oncology internal medicine in East Setauket, NY with 47 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Rocco Caruso, M.D. NPI is 1285630731. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Graduation Year:1979

The provider's business location address is:

235 N BELLE MEAD RD
EAST SETAUKET, NY
ZIP 11733-456
Phone: (631) 751-3000
Fax: (631) 675-2001

The NPI 1285630731 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Uric acid level, blood (HCPCS:84550)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Protein measurement, serum (HCPCS:84165)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Red blood count, manual test (HCPCS:85044)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Blood test, clotting time (HCPCS:85610)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Vitamin d-3 level (HCPCS:82306)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Folic acid level, serum (HCPCS:82746)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Drawing of blood for a medical problem (HCPCS:99195)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Hemoglobin a1c level (HCPCS:83036)
• Injection of drug or substance into vein (HCPCS:96374)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Testosterone (hormone) level, total (HCPCS:84403)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Acute hepatitis panel (HCPCS:80074)
• Urinalysis, manual test (HCPCS:81002)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Bilirubin level, total (HCPCS:82247)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Rheumatoid factor level (HCPCS:86431)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ige (immune system protein) level (HCPCS:82785)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Albumin (protein) level (HCPCS:82040)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Cholesterol level (HCPCS:82465)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Triglycerides level (HCPCS:84478)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)

The enumeration date for this NPI number is 6/21/2005 and was last updated on 10/15/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.